GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO., LTD. BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY
Patent Applications and Registrations
Patent applications and USPTO patent grants for GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO., LTD. BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY.The latest application filed is for "pyrazolopyridine compound as ret inhibitor and application thereof".
- GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO., LTD. BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY - Guangzhou, Guangdong CN
- Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory - Guangzhou N/A CN
| Patent | Date |
|---|---|
| Pyrazolopyridine Compound As Ret Inhibitor And Application Thereof App 20220220104 - WANG; Jiansong ; et al. | 2022-07-14 |
| Nitrogen-containing Spiro Derivative As Ret Inhibitor App 20220204507 - WANG; Jiansong ; et al. | 2022-06-30 |
| S-(carboxymethyl)-cysteine pharmaceutical compound and preparation method and use thereof Grant 10,251,854 - Chen , et al. | 2019-04-09 |
| S-(carboxymethyl)-cysteine Pharmaceutical Compound And Preparation Method And Use Thereof App 20170333374 - Chen; Mao ; et al. | 2017-11-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 